Program on an FDA Approved Treatment Option
YOU ARE CORDIALLY INVITED TO A VIRTUAL PROGRAM
A program on an FDA approved treatment option in locally advanced or mUC for patients who have previously received a PD-1 or PD-L1 inhibitor and platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced, or metastatic setting.
Nataliya Mar, MD
University of California Irvine
Kindly Reply by
June 9, 2020
In the RSVP, please include your Name, Contact
Information, Organization, and Specialty.